Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$884M |
| 2 |
Tesla
TSLA
|
+$641M |
| 3 |
Visa
V
|
+$520M |
| 4 |
Amazon
AMZN
|
+$457M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.14B |
| 2 |
Apple
AAPL
|
+$916M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$907M |
| 4 |
Microsoft
MSFT
|
+$832M |
| 5 |
Privia Health
PRVA
|
+$655M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.24% |
| 2 | Financials | 8.33% |
| 3 | Healthcare | 8.04% |
| 4 | Consumer Discretionary | 7.57% |
| 5 | Industrials | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
RE/MAX Holdings
RMAX
$207M
| $3.54M | ﹤0.01% |
183,915
-64,568
| -26% | -$1.21M |
|
3352
Bank of America Series L
BAC.PRL
$3.99B
| $3.54M | ﹤0.01% |
3,021
-215
| -7% | -$252K |
|
|
KNSW
3353
DELISTED
KnightSwan Acquisition Corporation
KNSW
| $3.54M | ﹤0.01% |
334,648
| – | – |
|
3354
nCino
NCNO
$2.11B
| $3.53M | ﹤0.01% |
117,102
+80,860
| +223% | +$2.06M |
|
3355
Theravance Biopharma
TBPH
$876M
| $3.53M | ﹤0.01% |
340,599
+4,172
| +1% | +$46.1K |
|
3356
First Bancorp
FBNC
$2.68B
| $3.52M | ﹤0.01% |
118,292
+41,265
| +54% | +$1.3M |
|
3357
WisdomTree US High Dividend Fund
DHS
$1.57B
| $3.52M | ﹤0.01% |
44,188
+35,325
| +399% | +$2.83M |
|
3358
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.13B
| $3.51M | ﹤0.01% |
75,321
| – | – |
|
3359
4D Molecular Therapeutics
FDMT
$537M
| $3.51M | ﹤0.01% |
194,265
-3,537
| -2% | -$65.1K |
|
|
RAPT
3360
DELISTED
RAPT Therapeutics
RAPT
| $3.51M | ﹤0.01% |
23,460
+1,702
| +8% | +$265K |
|
|
AVDL
3361
DELISTED
Avadel Pharmaceuticals
AVDL
| $3.51M | ﹤0.01% |
212,799
+160,431
| +306% | +$2.09M |
|
3362
BGC Group
BGC
$5.18B
| $3.5M | ﹤0.01% |
790,610
+42,815
| +6% | +$190K |
|
3363
CALL
Agnico Eagle Mines
AEM
$83.8B
| $3.5M | ﹤0.01% |
70,000
| – | – |
|
|
3364
PUT
Agnico Eagle Mines
AEM
$83.8B
| $3.5M | ﹤0.01% |
70,000
| – | – |
|
3365
Sabesp
SBS
$19.1B
| $3.49M | ﹤0.01% |
1,519,849
-1,049,847
| -41% | -$2.1M |
|
3366
Kodiak Sciences
KOD
$2.73B
| $3.49M | ﹤0.01% |
505,597
+103,052
| +26% | +$630K |
|
3367
Clearwater Paper
CLW
$367M
| $3.49M | ﹤0.01% |
111,308
+41,333
| +59% | +$1.33M |
|
|
BLUE
3368
DELISTED
bluebird bio
BLUE
| $3.48M | ﹤0.01% |
52,930
-27,458
| -34% | -$2.01M |
|
3369
FLEX LNG
FLNG
$1.63B
| $3.47M | ﹤0.01% |
113,633
-105,849
| -48% | -$3.39M |
|
3370
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$765M
| $3.47M | ﹤0.01% |
57,711
+1,505
| +3% | +$83.6K |
|
3371
Capitol Federal Financial
CFFN
$1.12B
| $3.46M | ﹤0.01% |
560,911
+313,009
| +126% | +$1.95M |
|
3372
CALL
ScottsMiracle-Gro
SMG
$3.85B
| $3.44M | ﹤0.01% |
+54,900
| New | +$3.68M |
|
3373
Byline Bancorp
BY
$1.79B
| $3.44M | ﹤0.01% |
190,176
+20,086
| +12% | +$378K |
|
|
ZEUS
3374
DELISTED
Olympic Steel
ZEUS
| $3.44M | ﹤0.01% |
70,195
+35,499
| +102% | +$1.67M |
|
3375
Shinhan Financial Group
SHG
$34B
| $3.43M | ﹤0.01% |
131,540
-380,815
| -74% | -$10.1M |
|
Similar funds
Goldman Sachs's Q2 2023 Portfolio in Review
As of Q2 2023, Goldman Sachs held 6,313 positions worth $466B, up 7.1% from $435B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs's Q2 2023 filing shows 443 new, 2,418 increased, 2,272 reduced and 593 closed positions. Its largest new stake was Pelagos Insurance Capital: 15,246,144 shares worth $208M. The largest sale was Invesco QQQ Trust, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q2 2023 buy was Pelagos Insurance Capital: 15,246,144 shares worth $208M.
- Goldman Sachs added most to Alphabet (Google) Class A in Q2 2023, an estimated $884M increase.
- Goldman Sachs's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.14B.
- Goldman Sachs fully exited DCP Midstream, LP in Q2 2023, selling an estimated $250M.
- Goldman Sachs's ten largest holdings make up 19% of its $466B portfolio in Q2 2023.
- Goldman Sachs opened 443 new positions and closed 593 in Q2 2023.
- Goldman Sachs's portfolio value rose 7.1% quarter-over-quarter to $466B.
Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.